Pharmacological profiles of a potential LTB4-antagonist, SM-9064
- 1 July 1986
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 138 (2) , 540-546
- https://doi.org/10.1016/s0006-291x(86)80530-7
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Immunoregulation by leukotrienes and other lipoxygenase metabolitesImmunology Today, 1985
- Identification of Chemotactic Lipoxygenase Products of Arachidonate Metabolism in Psoriatic SkinJournal of Investigative Dermatology, 1984
- Dexamethasone inhibits generation in inflammatory sites of the chemotactic activity attributable to leukotriene B4Biochemical and Biophysical Research Communications, 1984
- LEUKOTRIENE B4, AN INFLAMMATORY MEDIATOR IN GOUTThe Lancet, 1982
- Inhibition of leukotriene B4-induced neutrophil degranulation by leukotriene B4-dimethylamideBiochemical and Biophysical Research Communications, 1982
- Novel structural determinants of the human neutrophil chemotactic activity of leukotriene B.The Journal of Experimental Medicine, 1981
- Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis.Journal of Clinical Investigation, 1980
- Leukotriene B: a potential mediator of inflammationJournal of Pharmacy and Pharmacology, 1980
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980
- Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternate complement pathwaysClinical Immunology and Immunopathology, 1975